Sanofi

We chase the miracles of science so you can chase your dreams.

Discover more

People Stories

We’re proud to spotlight those who inspire us to keep going further in the work we do.

A woman wearing a black wetsuit holds a surfboard under blue skies and sunshine while looking out to the horizon with a hopeful and determined expression.​

Céline, living with secondary progressive multiple sclerosis

France

Two women in black wetsuits standing on a beach with a surfboard, ready for surfing

The Power of Chasing A Dream

Every day, we chase the miracles of science to improve people’s lives. We apply our deep understanding of the immune system to develop breakthrough innovations in medicines and vaccines so you can focus on what matters most, chasing your dreams. If you’re chasing your dreams, remember... you’re not alone. We’re right beside you. 


Our Latest Articles

Overhead view of a doctor in white and patient in striped shirt in consultation, with medical equipment including a stethoscope and blood pressure monitor on the desk between them

Your Health

December 17, 2025

The Cause of COPD You Don't Know: Alpha-1 Antitrypsin Deficiency

We are an R&D driven, AI-powered biopharmaceutical company committed to improving people’s lives and delivering compelling growth

About Us

Who We Are

We are an R&D driven,
AI-powered biopharma company committed to improving people’s lives and creating compelling growth.

Our Pipeline

5

Therapeutic areas

93

Compounds in clinical development

26

Clinical trials in phase 3

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Our Latest Press Releases


December 17, 2025
Press release: Availability of the Q4 2025 Aide memoire

December 17, 2025
Press Release: Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema

December 15, 2025
Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis

December 15, 2025
Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis